APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alpha L-Iduronidase

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Alpha L-Iduronidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026192 pages

Choose your research edition.

Industry ResearchAlpha L-Iduronidase Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Alpha L-Iduronidase Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Alpha L-Iduronidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alpha L-Iduronidase Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Alpha L-Iduronidase Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Alpha L-Iduronidase market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Alpha L-Iduronidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alpha L-Iduronidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alpha L-Iduronidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Alpha L-Iduronidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alpha L-Iduronidase include ArmaGen Inc, BioStrategies LC, Denali Therapeutics Inc, EdiGene Inc, Gain Therapeutics Inc, Immusoft Corp, JCR Pharmaceuticals Co Ltd, Orchard Therapeutics Plc and Ossianix Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Alpha L-Iduronidase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alpha L-Iduronidase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alpha L-Iduronidase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alpha L-Iduronidase market size, projected growth trends, production technologies, key applications, and end-use industries.

Alpha L-Iduronidase Segment by Company

ArmaGen Inc

BioStrategies LC

Denali Therapeutics Inc

EdiGene Inc

Gain Therapeutics Inc

Immusoft Corp

JCR Pharmaceuticals Co Ltd

Orchard Therapeutics Plc

Ossianix Inc

Rain Bio Inc

RegenxBio Inc

Tega Therapeutics Inc

Alpha L-Iduronidase Segment by Type

IDUA

EC 3.2.1.76

Alpha L-Iduronidase Segment by Application

Oncology

Dermatology

Immunology

Musculoskeletal Disorders

Alpha L-Iduronidase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha L-Iduronidase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alpha L-Iduronidase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha L-Iduronidase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alpha L-Iduronidase market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alpha L-Iduronidase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Alpha L-Iduronidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Alpha L-Iduronidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Alpha L-Iduronidase Industry Trends Table 2. Alpha L-Iduronidase Industry Drivers Table 3. Alpha L-Iduronidase Industry Opportunities and Challenges Table 4. Alpha L-Iduronidase Industry Restraints Table 5. Global Alpha L-Iduronidase Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Alpha L-Iduronidase Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Alpha L-Iduronidase Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Alpha L-Iduronidase Sales Market Share by Manufacturers Table 9. Global Alpha L-Iduronidase Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Alpha L-Iduronidase Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Alpha L-Iduronidase Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Alpha L-Iduronidase Manufacturers, Product Type & Application Table 13. Global Alpha L-Iduronidase Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Alpha L-Iduronidase by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of IDUA Table 17. Major Manufacturers of EC 3.2.1.76 Table 18. Global Alpha L-Iduronidase Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Alpha L-Iduronidase Sales by Type (2021-2026) & (K Units) Table 20. Global Alpha L-Iduronidase Sales by Type (2027-2032) & (K Units) Table 21. Global Alpha L-Iduronidase Sales Market Share by Type (2021-2026) Table 22. Global Alpha L-Iduronidase Sales Market Share by Type (2027-2032) Table 23. Global Alpha L-Iduronidase Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Alpha L-Iduronidase Revenue by Type (2021-2026) & (K Units) Table 25. Global Alpha L-Iduronidase Revenue by Type (2027-2032) & (K Units) Table 26. Global Alpha L-Iduronidase Revenue Market Share by Type (2021-2026) Table 27. Global Alpha L-Iduronidase Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Oncology Table 29. Major Manufacturers of Dermatology Table 30. Major Manufacturers of Immunology Table 31. Major Manufacturers of Musculoskeletal Disorders Table 32. Global Alpha L-Iduronidase Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Alpha L-Iduronidase Sales by Application (2021-2026) & (K Units) Table 34. Global Alpha L-Iduronidase Sales by Application (2027-2032) & (K Units) Table 35. Global Alpha L-Iduronidase Sales Market Share by Application (2021-2026) Table 36. Global Alpha L-Iduronidase Sales Market Share by Application (2027-2032) Table 37. Global Alpha L-Iduronidase Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Alpha L-Iduronidase Revenue by Application (2021-2026) & (K Units) Table 39. Global Alpha L-Iduronidase Revenue by Application (2027-2032) & (K Units) Table 40. Global Alpha L-Iduronidase Revenue Market Share by Application (2021-2026) Table 41. Global Alpha L-Iduronidase Revenue Market Share by Application (2027-2032) Table 42. Global Alpha L-Iduronidase Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Alpha L-Iduronidase Sales by Region (2021-2026) & (K Units) Table 44. Global Alpha L-Iduronidase Sales Market Share by Region (2021-2026) Table 45. Global Alpha L-Iduronidase Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Alpha L-Iduronidase Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Alpha L-Iduronidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Alpha L-Iduronidase Sales by Country (2021-2026) & (K Units) Table 49. North America Alpha L-Iduronidase Sales by Country (2027-2032) & (K Units) Table 50. Europe Alpha L-Iduronidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Alpha L-Iduronidase Sales by Country (2021-2026) & (K Units) Table 52. Europe Alpha L-Iduronidase Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Alpha L-Iduronidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Alpha L-Iduronidase Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Alpha L-Iduronidase Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Alpha L-Iduronidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Alpha L-Iduronidase Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Alpha L-Iduronidase Sales by Country (2027-2032) & (K Units) Table 59. Global Alpha L-Iduronidase Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Alpha L-Iduronidase Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Alpha L-Iduronidase Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Alpha L-Iduronidase Revenue Market Share by Region (2021-2026) Table 63. Global Alpha L-Iduronidase Revenue Market Share by Region (2027-2032) Table 64. ArmaGen Inc Company Information Table 65. ArmaGen Inc Business Overview Table 66. ArmaGen Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. ArmaGen Inc Alpha L-Iduronidase Product Portfolio Table 68. ArmaGen Inc Recent Development Table 69. BioStrategies LC Company Information Table 70. BioStrategies LC Business Overview Table 71. BioStrategies LC Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. BioStrategies LC Alpha L-Iduronidase Product Portfolio Table 73. BioStrategies LC Recent Development Table 74. Denali Therapeutics Inc Company Information Table 75. Denali Therapeutics Inc Business Overview Table 76. Denali Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Denali Therapeutics Inc Alpha L-Iduronidase Product Portfolio Table 78. Denali Therapeutics Inc Recent Development Table 79. EdiGene Inc Company Information Table 80. EdiGene Inc Business Overview Table 81. EdiGene Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. EdiGene Inc Alpha L-Iduronidase Product Portfolio Table 83. EdiGene Inc Recent Development Table 84. Gain Therapeutics Inc Company Information Table 85. Gain Therapeutics Inc Business Overview Table 86. Gain Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Gain Therapeutics Inc Alpha L-Iduronidase Product Portfolio Table 88. Gain Therapeutics Inc Recent Development Table 89. Immusoft Corp Company Information Table 90. Immusoft Corp Business Overview Table 91. Immusoft Corp Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Immusoft Corp Alpha L-Iduronidase Product Portfolio Table 93. Immusoft Corp Recent Development Table 94. JCR Pharmaceuticals Co Ltd Company Information Table 95. JCR Pharmaceuticals Co Ltd Business Overview Table 96. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product Portfolio Table 98. JCR Pharmaceuticals Co Ltd Recent Development Table 99. Orchard Therapeutics Plc Company Information Table 100. Orchard Therapeutics Plc Business Overview Table 101. Orchard Therapeutics Plc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Orchard Therapeutics Plc Alpha L-Iduronidase Product Portfolio Table 103. Orchard Therapeutics Plc Recent Development Table 104. Ossianix Inc Company Information Table 105. Ossianix Inc Business Overview Table 106. Ossianix Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Ossianix Inc Alpha L-Iduronidase Product Portfolio Table 108. Ossianix Inc Recent Development Table 109. Rain Bio Inc Company Information Table 110. Rain Bio Inc Business Overview Table 111. Rain Bio Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Rain Bio Inc Alpha L-Iduronidase Product Portfolio Table 113. Rain Bio Inc Recent Development Table 114. RegenxBio Inc Company Information Table 115. RegenxBio Inc Business Overview Table 116. RegenxBio Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. RegenxBio Inc Alpha L-Iduronidase Product Portfolio Table 118. RegenxBio Inc Recent Development Table 119. Tega Therapeutics Inc Company Information Table 120. Tega Therapeutics Inc Business Overview Table 121. Tega Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Tega Therapeutics Inc Alpha L-Iduronidase Product Portfolio Table 123. Tega Therapeutics Inc Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Alpha L-Iduronidase Distributors List Table 127. Alpha L-Iduronidase Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Alpha L-Iduronidase Product Image Figure 2. Global Alpha L-Iduronidase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alpha L-Iduronidase Market Size (2021-2032) & (US$ Million) Figure 4. Global Alpha L-Iduronidase Sales (2021-2032) & (K Units) Figure 5. Global Alpha L-Iduronidase Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Alpha L-Iduronidase Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. IDUA Image Figure 9. EC 3.2.1.76 Image Figure 10. Global Alpha L-Iduronidase Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Alpha L-Iduronidase Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Alpha L-Iduronidase Sales Market Share by Type (2021-2032) Figure 13. Global Alpha L-Iduronidase Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Alpha L-Iduronidase Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Alpha L-Iduronidase Revenue Market Share by Type (2021-2032) Figure 16. Oncology Image Figure 17. Dermatology Image Figure 18. Immunology Image Figure 19. Musculoskeletal Disorders Image Figure 20. Global Alpha L-Iduronidase Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Alpha L-Iduronidase Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Alpha L-Iduronidase Sales Market Share by Application (2021-2032) Figure 23. Global Alpha L-Iduronidase Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Alpha L-Iduronidase Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Alpha L-Iduronidase Revenue Market Share by Application (2021-2032) Figure 26. North America Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Alpha L-Iduronidase Sales Market Share by Country (2021-2032) Figure 28. U.S. Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Alpha L-Iduronidase Sales Market Share by Country (2021-2032) Figure 33. Germany Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Alpha L-Iduronidase Sales Market Share by Country (2021-2032) Figure 40. China Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Alpha L-Iduronidase Sales Market Share by Country (2021-2032) Figure 48. Brazil Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Alpha L-Iduronidase Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Alpha L-Iduronidase Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Alpha L-Iduronidase Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Alpha L-Iduronidase Revenue (2021-2032) & (US$ Million) Figure 59. North America Alpha L-Iduronidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Alpha L-Iduronidase Revenue (2021-2032) & (US$ Million) Figure 61. Europe Alpha L-Iduronidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Alpha L-Iduronidase Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Alpha L-Iduronidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Alpha L-Iduronidase Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Alpha L-Iduronidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Alpha L-Iduronidase Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Alpha L-Iduronidase Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • IDUA
  • EC 3.2.1.76
Applications
  • Oncology
  • Dermatology
  • Immunology
  • Musculoskeletal Disorders
Companies covered
  • ArmaGen Inc
  • BioStrategies LC
  • Denali Therapeutics Inc
  • EdiGene Inc
  • Gain Therapeutics Inc
  • Immusoft Corp
  • JCR Pharmaceuticals Co Ltd
  • Orchard Therapeutics Plc
  • Ossianix Inc
  • Rain Bio Inc
  • RegenxBio Inc
  • Tega Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Alpha L-Iduronidase Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Alpha L-Iduronidase Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Alpha L-Iduronidase Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Alpha L-Iduronidase Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Alpha L-Iduronidase Market Dynamics
  1. 2.1 Alpha L-Iduronidase Industry Trends
  2. 2.2 Alpha L-Iduronidase Industry Drivers
  3. 2.3 Alpha L-Iduronidase Industry Opportunities and Challenges
  4. 2.4 Alpha L-Iduronidase Industry Restraints
3 Alpha L-Iduronidase Market by Manufacturers
  1. 3.1 Global Alpha L-Iduronidase Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Alpha L-Iduronidase Sales by Manufacturers (2021-2026)
  3. 3.3 Global Alpha L-Iduronidase Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Alpha L-Iduronidase Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alpha L-Iduronidase Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Alpha L-Iduronidase Manufacturers, Product Type & Application
  7. 3.7 Global Alpha L-Iduronidase Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alpha L-Iduronidase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alpha L-Iduronidase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alpha L-Iduronidase Tier 1, Tier 2, and Tier 3
4 Alpha L-Iduronidase Market by Type
  1. 4.1 Alpha L-Iduronidase Type Introduction
  2. 4.1.1 IDUA
  3. 4.1.2 EC 3.2.1.76
  4. 4.2 Global Alpha L-Iduronidase Sales by Type
  5. 4.2.1 Global Alpha L-Iduronidase Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Alpha L-Iduronidase Sales by Type (2021-2032)
  7. 4.2.3 Global Alpha L-Iduronidase Sales Market Share by Type (2021-2032)
  8. 4.3 Global Alpha L-Iduronidase Revenue by Type
  9. 4.3.1 Global Alpha L-Iduronidase Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Alpha L-Iduronidase Revenue by Type (2021-2032)
  11. 4.3.3 Global Alpha L-Iduronidase Revenue Market Share by Type (2021-2032)
5 Alpha L-Iduronidase Market by Application
  1. 5.1 Alpha L-Iduronidase Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Dermatology
  4. 5.1.3 Immunology
  5. 5.1.4 Musculoskeletal Disorders
  6. 5.2 Global Alpha L-Iduronidase Sales by Application
  7. 5.2.1 Global Alpha L-Iduronidase Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Alpha L-Iduronidase Sales by Application (2021-2032)
  9. 5.2.3 Global Alpha L-Iduronidase Sales Market Share by Application (2021-2032)
  10. 5.3 Global Alpha L-Iduronidase Revenue by Application
  11. 5.3.1 Global Alpha L-Iduronidase Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Alpha L-Iduronidase Revenue by Application (2021-2032)
  13. 5.3.3 Global Alpha L-Iduronidase Revenue Market Share by Application (2021-2032)
6 Global Alpha L-Iduronidase Sales by Region
  1. 6.1 Global Alpha L-Iduronidase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alpha L-Iduronidase Sales by Region (2021-2032)
  3. 6.2.1 Global Alpha L-Iduronidase Sales by Region (2021-2026)
  4. 6.2.2 Global Alpha L-Iduronidase Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Alpha L-Iduronidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Alpha L-Iduronidase Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Alpha L-Iduronidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Alpha L-Iduronidase Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Alpha L-Iduronidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Alpha L-Iduronidase Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Alpha L-Iduronidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Alpha L-Iduronidase Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Alpha L-Iduronidase Revenue by Region
  1. 7.1 Global Alpha L-Iduronidase Revenue by Region
  2. 7.1.1 Global Alpha L-Iduronidase Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Alpha L-Iduronidase Revenue by Region (2021-2026)
  4. 7.1.3 Global Alpha L-Iduronidase Revenue by Region (2027-2032)
  5. 7.1.4 Global Alpha L-Iduronidase Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Alpha L-Iduronidase Revenue (2021-2032)
  8. 7.2.2 North America Alpha L-Iduronidase Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Alpha L-Iduronidase Revenue (2021-2032)
  11. 7.3.2 Europe Alpha L-Iduronidase Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Alpha L-Iduronidase Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Alpha L-Iduronidase Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Alpha L-Iduronidase Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Alpha L-Iduronidase Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ArmaGen Inc
  2. 8.1.1 ArmaGen Inc Company Information
  3. 8.1.2 ArmaGen Inc Business Overview
  4. 8.1.3 ArmaGen Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ArmaGen Inc Alpha L-Iduronidase Product Portfolio
  6. 8.1.5 ArmaGen Inc Recent Developments
  7. 8.2 BioStrategies LC
  8. 8.2.1 BioStrategies LC Company Information
  9. 8.2.2 BioStrategies LC Business Overview
  10. 8.2.3 BioStrategies LC Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BioStrategies LC Alpha L-Iduronidase Product Portfolio
  12. 8.2.5 BioStrategies LC Recent Developments
  13. 8.3 Denali Therapeutics Inc
  14. 8.3.1 Denali Therapeutics Inc Company Information
  15. 8.3.2 Denali Therapeutics Inc Business Overview
  16. 8.3.3 Denali Therapeutics Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Denali Therapeutics Inc Alpha L-Iduronidase Product Portfolio
  18. 8.3.5 Denali Therapeutics Inc Recent Developments
  19. 8.4 EdiGene Inc
  20. 8.4.1 EdiGene Inc Company Information
  21. 8.4.2 EdiGene Inc Business Overview
  22. 8.4.3 EdiGene Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 EdiGene Inc Alpha L-Iduronidase Product Portfolio
  24. 8.4.5 EdiGene Inc Recent Developments
  25. 8.5 Gain Therapeutics Inc
  26. 8.5.1 Gain Therapeutics Inc Company Information
  27. 8.5.2 Gain Therapeutics Inc Business Overview
  28. 8.5.3 Gain Therapeutics Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Gain Therapeutics Inc Alpha L-Iduronidase Product Portfolio
  30. 8.5.5 Gain Therapeutics Inc Recent Developments
  31. 8.6 Immusoft Corp
  32. 8.6.1 Immusoft Corp Company Information
  33. 8.6.2 Immusoft Corp Business Overview
  34. 8.6.3 Immusoft Corp Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Immusoft Corp Alpha L-Iduronidase Product Portfolio
  36. 8.6.5 Immusoft Corp Recent Developments
  37. 8.7 JCR Pharmaceuticals Co Ltd
  38. 8.7.1 JCR Pharmaceuticals Co Ltd Company Information
  39. 8.7.2 JCR Pharmaceuticals Co Ltd Business Overview
  40. 8.7.3 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product Portfolio
  42. 8.7.5 JCR Pharmaceuticals Co Ltd Recent Developments
  43. 8.8 Orchard Therapeutics Plc
  44. 8.8.1 Orchard Therapeutics Plc Company Information
  45. 8.8.2 Orchard Therapeutics Plc Business Overview
  46. 8.8.3 Orchard Therapeutics Plc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Orchard Therapeutics Plc Alpha L-Iduronidase Product Portfolio
  48. 8.8.5 Orchard Therapeutics Plc Recent Developments
  49. 8.9 Ossianix Inc
  50. 8.9.1 Ossianix Inc Company Information
  51. 8.9.2 Ossianix Inc Business Overview
  52. 8.9.3 Ossianix Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ossianix Inc Alpha L-Iduronidase Product Portfolio
  54. 8.9.5 Ossianix Inc Recent Developments
  55. 8.10 Rain Bio Inc
  56. 8.10.1 Rain Bio Inc Company Information
  57. 8.10.2 Rain Bio Inc Business Overview
  58. 8.10.3 Rain Bio Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Rain Bio Inc Alpha L-Iduronidase Product Portfolio
  60. 8.10.5 Rain Bio Inc Recent Developments
  61. 8.11 RegenxBio Inc
  62. 8.11.1 RegenxBio Inc Company Information
  63. 8.11.2 RegenxBio Inc Business Overview
  64. 8.11.3 RegenxBio Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 RegenxBio Inc Alpha L-Iduronidase Product Portfolio
  66. 8.11.5 RegenxBio Inc Recent Developments
  67. 8.12 Tega Therapeutics Inc
  68. 8.12.1 Tega Therapeutics Inc Company Information
  69. 8.12.2 Tega Therapeutics Inc Business Overview
  70. 8.12.3 Tega Therapeutics Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Tega Therapeutics Inc Alpha L-Iduronidase Product Portfolio
  72. 8.12.5 Tega Therapeutics Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alpha L-Iduronidase Value Chain Analysis
  2. 9.1.1 Alpha L-Iduronidase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alpha L-Iduronidase Production Mode & Process
  6. 9.2 Alpha L-Iduronidase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alpha L-Iduronidase Distributors
  9. 9.2.3 Alpha L-Iduronidase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst